Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Clin Transl Sci ; 17(9): e70010, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39222377

ABSTRACT

Tepotinib is approved for the treatment of patients with non-small-cell lung cancer harboring MET exon 14 skipping alterations. While edema is the most prevalent adverse event (AE) and a known class effect of MET inhibitors including tepotinib, there is still limited understanding about the factors contributing to its occurrence. Herein, we apply machine learning (ML)-based approaches to predict the likelihood of occurrence of edema in patients undergoing tepotinib treatment, and to identify factors influencing its development over time. Data from 612 patients receiving tepotinib in five Phase I/II studies were modeled with two ML algorithms, Random Forest, and Gradient Boosting Trees, to predict edema AE incidence and severity. Probability calibration was applied to give a realistic estimation of the likelihood of edema AE. Best model was tested on follow-up data and on data from clinical studies unused while training. Results showed high performances across all the tested settings, with F1 scores up to 0.961 when retraining the model with the most relevant covariates. The use of ML explainability methods identified serum albumin as the most informative longitudinal covariate, and higher age as associated with higher probabilities of more severe edema. The developed methodological framework enables the use of ML algorithms for analyzing clinical safety data and exploiting longitudinal information through various covariate engineering approaches. Probability calibration ensures the accurate estimation of the likelihood of the AE occurrence, while explainability tools can identify factors contributing to model predictions, hence supporting population and individual patient-level interpretation.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Edema , Machine Learning , Humans , Edema/chemically induced , Female , Male , Middle Aged , Carcinoma, Non-Small-Cell Lung/drug therapy , Aged , Lung Neoplasms/drug therapy , Clinical Trials, Phase II as Topic , Pyrimidines/adverse effects , Pyrimidines/administration & dosage , Clinical Trials, Phase I as Topic , Adult , Antineoplastic Agents/adverse effects , Protein Kinase Inhibitors/adverse effects , Piperidines , Pyridazines
2.
CPT Pharmacometrics Syst Pharmacol ; 12(8): 1170-1181, 2023 08.
Article in English | MEDLINE | ID: mdl-37328961

ABSTRACT

The development of immune checkpoint inhibitors (ICIs) has revolutionized cancer therapy but only a fraction of patients benefits from this therapy. Model-informed drug development can be used to assess prognostic and predictive clinical factors or biomarkers associated with treatment response. Most pharmacometric models have thus far been developed using data from randomized clinical trials, and further studies are needed to translate their findings into the real-world setting. We developed a tumor growth inhibition model based on real-world clinical and imaging data in a population of 91 advanced melanoma patients receiving ICIs (i.e., ipilimumab, nivolumab, and pembrolizumab). Drug effect was modeled as an ON/OFF treatment effect, with a tumor killing rate constant identical for the three drugs. Significant and clinically relevant covariate effects of albumin, neutrophil to lymphocyte ratio, and Eastern Cooperative Oncology Group (ECOG) performance status were identified on the baseline tumor volume parameter, as well as NRAS mutation on tumor growth rate constant using standard pharmacometric approaches. In a population subgroup (n = 38), we had the opportunity to conduct an exploratory analysis of image-based covariates (i.e., radiomics features), by combining machine learning and conventional pharmacometric covariate selection approaches. Overall, we demonstrated an innovative pipeline for longitudinal analyses of clinical and imaging RWD with a high-dimensional covariate selection method that enabled the identification of factors associated with tumor dynamics. This study also provides a proof of concept for using radiomics features as model covariates.


Subject(s)
Electronic Health Records , Melanoma , Humans , Melanoma/drug therapy , Melanoma/pathology , Nivolumab , Ipilimumab , Immunotherapy/methods
3.
Stoch Environ Res Risk Assess ; 36(8): 2049-2069, 2022.
Article in English | MEDLINE | ID: mdl-36101650

ABSTRACT

With wind power providing an increasing amount of electricity worldwide, the quantification of its spatio-temporal variations and the related uncertainty is crucial for energy planners and policy-makers. Here, we propose a methodological framework which (1) uses machine learning to reconstruct a spatio-temporal field of wind speed on a regular grid from spatially irregularly distributed measurements and (2) transforms the wind speed to wind power estimates. Estimates of both model and prediction uncertainties, and of their propagation after transforming wind speed to power, are provided without any assumptions on data distributions. The methodology is applied to study hourly wind power potential on a grid of 250 × 250  m 2 for turbines of 100 m hub height in Switzerland, generating the first dataset of its type for the country. We show that the average annual power generation per turbine is 4.4 GWh. Results suggest that around 12,000 wind turbines could be installed on all 19,617 km 2 of available area in Switzerland resulting in a maximum technical wind potential of 53 TWh. To achieve the Swiss expansion goals of wind power for 2050, around 1000 turbines would be sufficient, corresponding to only 8% of the maximum estimated potential. Supplementary Information: The online version contains supplementary material available at 10.1007/s00477-022-02219-w.

4.
Sci Rep ; 10(1): 22243, 2020 12 17.
Article in English | MEDLINE | ID: mdl-33335159

ABSTRACT

As the role played by statistical and computational sciences in climate and environmental modelling and prediction becomes more important, Machine Learning researchers are becoming more aware of the relevance of their work to help tackle the climate crisis. Indeed, being universal nonlinear function approximation tools, Machine Learning algorithms are efficient in analysing and modelling spatially and temporally variable environmental data. While Deep Learning models have proved to be able to capture spatial, temporal, and spatio-temporal dependencies through their automatic feature representation learning, the problem of the interpolation of continuous spatio-temporal fields measured on a set of irregular points in space is still under-investigated. To fill this gap, we introduce here a framework for spatio-temporal prediction of climate and environmental data using deep learning. Specifically, we show how spatio-temporal processes can be decomposed in terms of a sum of products of temporally referenced basis functions, and of stochastic spatial coefficients which can be spatially modelled and mapped on a regular grid, allowing the reconstruction of the complete spatio-temporal signal. Applications on two case studies based on simulated and real-world data will show the effectiveness of the proposed framework in modelling coherent spatio-temporal fields.

SELECTION OF CITATIONS
SEARCH DETAIL